Insider Transactions Reported by 17 Insiders of EXAGEN INC.

Symbol
XGN on Nasdaq
Location
Vista, CA

Insiders trading volume in the past year

EXAGEN INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JOHN ABALLI President and CEO, Director $9,143,726 -$375,598 -3.9% 16 Oct 2025
NMSIC Co-Investment Fund, L.P. 10%+ Owner $5,804,561 -$1,155,000 -17% 25 Mar 2025
JAMES L. L. TULLIS 10%+ Owner $2,725,180 15 Jun 2023
Jeffrey G. Black Chief Financial Officer $2,669,564 -$200,362 -7% 02 Sep 2025
Kamal Adawi CFO and Corporate Secretary $465,536 04 Mar 2024
Mark Hazeltine Chief Business Officer $331,927 02 Mar 2023
Fortunato R. Rocca President and CEO, Director $210,595 01 Mar 2022
Debra Zack Chief Medical Officer $147,040 01 Mar 2022
SCOTT D. KAHN Director $53,700 10 Jun 2025
Tina Susan Nova Director $48,330 10 Jun 2025
Ana Hooker Director $32,220 10 Jun 2025
Brian Birk Director $32,220 09 Jun 2023
Wendy S. Johnson Director $32,220 09 Jun 2023
EBETUEL PALLARES Director $32,220 09 Jun 2023
Bruce C. Robertson Director $32,220 17 Jun 2021
Frank Stokes Director $32,220 10 Jun 2025
Paul Kim Director $32,220 10 Jun 2025

Recent Insider Transactions by Companies or Individuals for EXAGEN INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.